|

Verapamil Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: Isoptin Retard 240 MG, Verapamil Hydrochloride 240 MG

Pipeline

Phase 4: 1

Top Sponsors

  • Morten Steen Kvistholm Jensen1

Indications

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.